The EcoRV genetic polymorphism of human monoamine oxidase type A is not associated with Parkinson's disease and does not modify the effect of smokingon Parkinson's disease
P. Costa-mallen et al., The EcoRV genetic polymorphism of human monoamine oxidase type A is not associated with Parkinson's disease and does not modify the effect of smokingon Parkinson's disease, NEUROSCI L, 278(1-2), 2000, pp. 33-36
We previously observed an association with Parkinson's (PD), and modificati
on of the effect of smoking on PD, by a polymorphism of the monoamine oxida
se B (MAO-B) gene. The A form of monoamine oxidase (MAO-A) shares with MAO-
B many characteristics that could be relevant to PD, especially proneuroxic
ant bioactivation and dopamine metabolism. MAO-A is also inhibited by tobac
co smoke, which bears an apparent protective effect on PD. We investigated
the possibility that MAO-A genetic variants may also be involved in predisp
osition to PD and in modification of the effect of smoking. Three-hundred a
nd seventy-one subjects - 145 idiopathic PD cases and 226 age/gender-matche
d controls - were genotyped for the EcoRV polymorphism of MAO-A gene which
has been related to increased enzyme activity. MAO-A EcoRV polymorphism was
neither significantly associated with PD nor did it modify the inverse rel
ationship with smoking. These results suggest that the EcoRV polymorphism o
f MAO-A is not an important biomarker of PD risk. Published by Elsevier Sci
ence Ireland Ltd.